Skip to main content
. Author manuscript; available in PMC: 2014 Mar 24.
Published in final edited form as: Invest New Drugs. 2006 Nov 1;25(3):259–263. doi: 10.1007/s10637-006-9023-6

Figure 1.

Figure 1

Kaplan-Meier survival curves for the 55 patients in the CAI study (solid line) and the 164 patients in the NABTT reference group (broken line). The curve for the reference group is truncated at 48 months, though 3 patients had longer survival.